Skip to content
★ Sign in to follow
GJ

Guy J. Quigley

ProPhase Labs, Inc.
Total declarations
22
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (12 ops.)
€3.9M

Latest filing published 30 Dec 2010 for ProPhase Labs, Inc., €2,423.

Insider track record

Disclosed buys
0
Disclosed sells
12
Signal history

No signal scores available.

Guy J. Quigley: trading record in brief

Guy J. Quigley discloses dealings in ProPhase Labs, Inc. to SEC (Form 4). Between 21 March 2006 and 1 October 2010, the trades on record add up to 22 filings.

No open-market purchase appears, only 12 sales worth €3.9M. The rest of the record consists of 4 option exercises. 2011 to date brings no purchases and 3 sales.

The latest filing, published on 28 January 2011, reports an open-market sale of €815 in ProPhase Labs, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Guy J. Quigley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ▼
    10% OwnerExecutivesProPhase Labs, Inc.
    3,300 USD0SEC
    3,000 shares@ US$1.10Common Stock, $.0005 par value per shareSEC:0000921895-10-001995:0
  • ▼
    10% OwnerExecutivesProPhase Labs, Inc.
    1,110 USD0SEC
    1,000 shares@ US$1.11Common Stock, $.0005 par value per shareSEC:0000921895-10-001995:1
  • ◇
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    88,200 USD0SEC
    70,000 shares@ US$1.26Common Stock, $.0005 par value per shareSEC:0000921895-07-002211:0
  • ◇
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    56,910 USD0SEC
    70,000 shares@ US$0.813Common Stock, $.0005 par value per shareSEC:0000921895-07-002211:1
  • ◇
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    7,560 USD0SEC
    6,000 shares@ US$1.26Common Stock, $.0005 par value per shareSEC:0000921895-07-002211:2
  • ◇
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    2,439 USD0SEC
    3,000 shares@ US$0.813Common Stock, $.0005 par value per shareSEC:0000921895-07-002211:3
  • ●
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    125,000 USD0SEC
    50,000 shares@ US$2.50Common Stock, $.0005 par value per shareSEC:0000921895-06-002224:0
  • ▼
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    300,000 USD0SEC
    50,000 shares@ US$6.00Common Stock, $.0005 par value per shareSEC:0000921895-06-002224:1
  • ●
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    62,500 USD0SEC
    25,000 shares@ US$2.50Common Stock, $.0005 par value per shareSEC:0000921895-06-001101:0
  • ▼
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    250,000 USD0SEC
    25,000 shares@ US$10.00Common Stock, $.0005 par value per shareSEC:0000921895-06-001101:1
  • ●
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    507,719 USD0SEC
    290,125 shares@ US$1.75Common Stock, $.0005 par value per shareSEC:0000921895-06-000877:0
  • ▼
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    2M USD0SEC
    290,125 shares@ US$8.50Common Stock, $.0005 par value per shareSEC:0000921895-06-000877:1
  • ●
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    340,813 USD0SEC
    194,750 shares@ US$1.75Common Stock, $.0005 par value per shareSEC:0000921895-06-000877:2
  • ▼
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    2M USD0SEC
    194,750 shares@ US$8.50Common Stock, $.0005 par value per shareSEC:0000921895-06-000877:3
  • ●
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    17,281 USD0SEC
    9,875 shares@ US$1.75Common Stock, $.0005 par value per shareSEC:0000921895-06-000764:0
  • ▼
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    99,046 USD0SEC
    9,875 shares@ US$10.03Common Stock, $.0005 par value per shareSEC:0000921895-06-000764:1
  • ●
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    9,188 USD0SEC
    5,250 shares@ US$1.75Common Stock, $.0005 par value per shareSEC:0000921895-06-000764:2
  • ▼
    Chairman, President, CEOExecutivesProPhase Labs, Inc.
    52,658 USD0SEC
    5,250 shares@ US$10.03Common Stock, $.0005 par value per shareSEC:0000921895-06-000764:3

18 of 18 declarations